Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

TEM

Tempus AI Inc

Dec 12 • 03:14PM ET

42.86

Dollar change -0.33
Percentage change -0.75	%

Healthcare • Health Information Services • USA • NASD

Peers: ILMN EXAS GH TXG CRSP PACB NTLA EDIT CDNA TWST

| Held by: ARKK ARKG ROBT JTEK FPX THNQ ONEQ VTI VB VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-	Insider Own	67.12%	Shs Outstand	150.28M	Perf Week	-19.37%
Market Cap	6.75B	Forward P/E	-	EPS next Y	-	Insider Trans	-0.37%	Shs Float	51.77M	Perf Month	-37.00%
Income	-	PEG	-	EPS next Q	-0.15	Inst Own	19.74%	Short Float	9.86%	Perf Quarter	-13.19%
Sales	-	P/S	-	EPS this Y	-	Inst Trans	3.98%	Short Ratio	3.59	Perf Half Y	-
Book/sh	0.35	P/B	123.92	EPS next Y	-	ROA	-	Short Interest	5.11M	Perf Year	-
Cash/sh	2.96	P/C	14.47	EPS next 5Y	34.04%	ROE	-	52W Range	22.89 - 79.49	Perf YTD	6.50%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-46.08%	Beta	-
Dividend TTM	-	Quick Ratio	2.55	Sales past 5Y	-	Gross Margin	-	52W Low	87.26%	ATR (14)	5.97
Dividend Ex-Date	Jul 18, 2006	Current Ratio	2.69	EPS Y/Y TTM	-	Oper. Margin	-	RSI (14)	37.76	Volatility	9.22% 11.59%
Employees	-	Debt/Eq	8.78	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.67	Target Price	59.25
Option/Short	Yes / Yes	LT Debt/Eq	8.67	EPS Q/Q	-0.57%	Payout	-	Rel Volume	6.67	Prev Close	43.19
Sales Surprise	0.78%	EPS Surprise	6.05%	Sales Q/Q	79.80%	Earnings	Nov 07 AMC	Avg Volume	1.42M	Price	42.86
SMA20	-21.56%	SMA50	-18.53%	SMA200	-10.49%	Trades		Volume	8,426,564	Change	-0.75%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-09-24	Initiated	Guggenheim	Buy	$74
Nov-11-24	Downgrade	Stifel	Buy → Hold	$45 → $65
Oct-02-24	Downgrade	BofA Securities	Buy → Neutral	$45 → $60
Aug-12-24	Initiated	Piper Sandler	Neutral	$40
Jul-09-24	Initiated	William Blair	Outperform
Jul-09-24	Initiated	TD Cowen	Buy	$50
Jul-09-24	Initiated	Stifel	Buy	$45
Jul-09-24	Initiated	Needham	Buy	$47
Jul-09-24	Initiated	Morgan Stanley	Overweight	$44
Jul-09-24	Initiated	Loop Capital	Buy	$48
Jul-09-24	Initiated	Longbow	Buy	$48
Jul-09-24	Initiated	JP Morgan	Overweight	$42
Jul-09-24	Initiated	BofA Securities	Buy	$41

Show Previous Ratings

Today 12:02PM	Cathie Wood's ARK Sells $21.8M Tesla Shares, Buys $18.3M Tempus AI Stock (GuruFocus.com)
11:26AM	Healthcare Executives Embrace Generative AI to Boost Patient Outcomes (PR Newswire)
Dec-04-24 08:45AM	Artificial Intelligence (AI) Redefining Medical Diagnostics Industry That's Expected to be a $7.2 Billion Market by 2029 (GlobeNewswire)
Nov-29-24 12:29PM	Tempus AI, Inc (TEM) Stock Soars 75% Post-Earnings, but Stifel Downgrades to Hold Due to Overvaluation Concerns (Insider Monkey)
Nov-25-24 08:30AM	Tempus to Participate in the Piper Sandler 36th Annual Healthcare Conference (Business Wire) +9.03%
01:06AM	Loading…
01:06AM	Medtronic, Tempus testing AI to find potential TAVR patients (MedTech Dive)
Nov-20-24 08:45AM	Artificial Intelligence (AI) Reshaping Healthcare Industry with Unimaginable Potential (GlobeNewswire) +7.75%
Nov-12-24 08:30AM	Tempus Molecular Profiling Integration Now Available Through Flatirons OncoEMR (Business Wire) -12.34%
Nov-11-24 08:30AM	Tempus Publishes Study Highlighting Benefits of Concurrent RNA and DNA Sequencing in Advanced Cancer Care (Business Wire) +5.22%
Nov-08-24 08:30AM	Tempus Announces Nine Abstracts Accepted for Presentation at the 2024 Society for Immunotherapy of Cancer Annual Meeting (Business Wire) +29.90%
Nov-07-24 05:49PM	Tempus AI Inc (NASDAQ:TEM) Continues Strong Growth with 33% Revenue Increase, Price Target Raised to $56 (Insider Monkey)
04:30PM	Tempus Announces the Clinical Launch of its Immune Profile Score Algorithmic Test (Business Wire)
08:20AM	Exciting Growth Potential Ahead for Tempus AI (TEM) (Insider Monkey)
Nov-06-24 06:52AM	Tempus AI to buy genetic testing company for $600M (MedTech Dive) +28.02%
Nov-05-24 11:15PM	Tempus AI Reports Growth and Strategic Acquisition (TipRanks) -10.10%
08:43AM	Loading…
08:43AM	Q3 2024 Tempus AI Inc Earnings Call (Thomson Reuters StreetEvents)
02:10AM	Tempus AI Inc (TEM) Q3 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic ... (GuruFocus.com)
Nov-04-24 04:15PM	Tempus: Q3 Earnings Snapshot (Associated Press Finance) +7.47%
04:01PM	Tempus Reports Third Quarter 2024 Results and Agreement to Acquire Ambry Genetics (Business Wire)
Nov-03-24 08:06PM	Tempus to Report Third Quarter 2024 Financial Results on November 4 (Business Wire)
Oct-24-24 08:30AM	Tempus to Report Third Quarter 2024 Financial Results on November 7 (Business Wire)
Oct-22-24 09:39AM	Avacta partners Tempus AI to boost cancer therapy development (Pharmaceutical Technology)
Oct-21-24 07:00AM	Avacta and Tempus Enter Strategic Collaboration to Advance AI-Driven Drug Development in Oncology (GlobeNewswire)
Oct-12-24 09:59AM	Tempus AI, Inc (TEM): A Bull Case Theory (Insider Monkey)
Oct-11-24 10:13AM	Australian Vintage re-appoints former CEO after surprise exit in May (Just Drinks) +6.18%
Sep-27-24 06:32AM	Tempus AI expands oncology collaboration with Takeda (Pharmaceutical Technology)
Sep-26-24 08:30AM	Tempus Announces Expansion of Collaboration with Takeda to Leverage Multimodal Real-World Datasets and Biological Model Systems in Oncology Research and Development (Business Wire) +5.53%
Sep-16-24 03:09PM	Tempus AI Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating (Investor's Business Daily) +10.71%
Sep-13-24 08:30AM	Tempus Announces Four Abstracts Accepted For Presentation at the European Society for Medical Oncology Congress 2024 (Business Wire) +8.65%
Sep-12-24 08:30AM	Tempus Launches Beta Version of olivia, its AI-enabled Personal Health Concierge App for Patients (Business Wire)
10:15AM	Loading…
Sep-11-24 10:15AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
Sep-04-24 08:30AM	Tempus Announces Real World Data Collaboration with BioNTech (Business Wire)
Aug-30-24 10:30AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
Aug-28-24 08:30AM	Tempus to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference (Business Wire) -13.49%
Aug-27-24 11:40AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool) +13.15%
Aug-21-24 06:13PM	Why Tempus AI Stock Skyrocketed Nearly 22% Today (Motley Fool) +21.73% -9.71%
09:07AM	Is Tempus AI Inc (NASDAQ:TEM) The Best Small-Cap AI Stock to Buy? (Insider Monkey)
01:11AM	BerGenBio Second Quarter Results 2024: Solid clinical and financial progress (PR Newswire)
Aug-18-24 12:00PM	3 Stocks for the AI Age (InvestorPlace)
Aug-16-24 08:30AM	Personalis and Tempus Announce Expanded Collaboration (Business Wire) +7.80%
Aug-14-24 09:50AM	Examining the Role of AI in Advancing Healthcare Efficiency (PR Newswire)
Aug-08-24 12:16PM	Cathie Wood's Ark Invest is buying the dip on tech stocks (Yahoo Finance Video)
08:30AM	NPJ Precision Oncology Publishes Tempus Study on Validation of its HLA-LOH Investigational Assay (Business Wire)
06:20AM	7 Growth Stocks That Could 7X in the Next 7 Years (InvestorPlace)
Aug-06-24 04:42PM	Tempus: Q2 Earnings Snapshot (Associated Press Finance) +6.36%
04:01PM	Tempus Reports Second Quarter 2024 Results (Business Wire)
10:15AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
06:30AM	3 Under-The-Radar Healthcare Stocks to Buy for Outsized Returns (InvestorPlace)
Aug-02-24 09:55AM	What Makes Tempus AI (TEM) an Attractive Investment? (Insider Monkey)
06:43AM	3 AI-Powered Healthcare Stocks Transforming Medicine (InvestorPlace)
06:30AM	7 New Growth Stock Listings That Can Be Long-Term Wealth Creators (InvestorPlace)
Aug-01-24 08:30AM	Tempus Next Launches New Algorithm to Close Care Gaps in Guideline-Directed IHC Testing, Starting with HER2 (Business Wire) -9.24%
Jul-30-24 08:30AM	Tempus Announces Expanded Data and Sequencing Collaboration with Remix Therapeutics (Business Wire)
Jul-29-24 04:30PM	3 AI-in-Healthcare Stocks to Buy for Outsized Returns (InvestorPlace)
Jul-26-24 06:07AM	7 Growth Stocks That Can Create Millionaires by 2030 (InvestorPlace)
Jul-18-24 10:30AM	7 Millionaire-Making Growth Stocks to Buy and Forget (InvestorPlace)
08:30AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
Jul-17-24 09:30AM	Tempus to Report Second Quarter 2024 Financial Results on August 6 (Business Wire)
Jul-16-24 09:30AM	Tempus Expands Immuno-Oncology Portfolio with Launch of AI-enabled, Multimodal Immune Profile Algorithmic Tests (Business Wire) +11.31%
08:15AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
Jul-15-24 09:29PM	3 Under-the-Radar IPO Stocks to Buy Before They Double (InvestorPlace) -7.95%
Jul-10-24 09:30AM	Tempus Surpasses 500 Research Publications (Business Wire)
Jul-09-24 02:26PM	Why Wall Street Is Bullish on Healthcare Tech Stock Tempus AI (Investopedia)
10:16AM	Wall Street analysts bullish on genetic testing firm Tempus AI (Reuters)
09:35AM	Tempus AI initiated, Helios downgraded: Wall Street's top analyst calls (The Fly)
Jul-08-24 09:30AM	American Medical Association Grants PLA Code to Tempus Algorithmic Test, PurISTSM (Business Wire) +7.51%
Jul-05-24 07:45AM	IPO Watch: 3 New Stocks Worth a Strong Look (InvestorPlace) -10.21%
Jul-04-24 03:49PM	3 New IPOs That Could Be the Next Big Thing (InvestorPlace)
Jul-02-24 09:30AM	CMS Awards Tempus With Advanced Diagnostic Laboratory Test (ADLT) Status for its xT CDx Test (Business Wire) +7.92%
Jul-01-24 07:37AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday (InvestorPlace)
Jun-26-24 09:30AM	Tempus Receives U.S. FDA 510(k) Clearance for Tempus ECG-AF, an AI-based Algorithm that Identifies Patients at Increased Risk of AFib (Business Wire) +10.42%
Jun-25-24 09:30AM	Tempus Announces Collaboration with United Therapeutics to Study Use of AI to Detect Patients at Risk for Pulmonary Hypertension (Business Wire)
Jun-14-24 06:16PM	Musk pay package, cruise line pressures: Market Domination (Yahoo Finance Video)
03:57PM	Tempus AI stock rises after Nasdaq debut via IPO (Yahoo Finance Video)
Jun-13-24 06:44PM	Tempus Announces Pricing of Initial Public Offering (Business Wire)

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
KEYWELL BRADLEY A	10% Owner	Dec 11 '24	Sale	42.95	395,800	16,997,810	16,164,449	Dec 12 08:33 AM
JENNIFER A DOUDNA	Director	Dec 11 '24	Proposed Sale	45.00	2,146	96,570		Dec 11 05:03 PM
DAVID R. EPSTEIN	Director	Dec 11 '24	Proposed Sale	45.00	1,240	55,800		Dec 11 05:03 PM
JAMES ROGERS	Officer	Dec 11 '24	Proposed Sale	45.00	83,025	3,736,125		Dec 11 05:02 PM
ANDREW KEITH POLOVIN	Officer	Dec 11 '24	Proposed Sale	45.00	51,504	2,317,680		Dec 11 05:01 PM
RYAN FUKUSHIMA	Officer	Dec 11 '24	Proposed Sale	45.00	180,000	8,100,000		Dec 11 05:01 PM
ERIK PHELPS	Officer	Dec 11 '24	Proposed Sale	45.00	82,109	3,694,905		Dec 11 05:01 PM
REVOLUTION GROWTH III, LP	Shareholder	Dec 11 '24	Proposed Sale	45.00	400,000	18,000,000		Dec 11 04:56 PM
Tempus AI, Inc.	10% Owner	Aug 16 '24	Buy	5.07	3,500,000	17,745,000	12,718,800	Aug 20 04:17 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

TEM

Tempus AI Inc

Upgrade your FINVIZ experience